India's First mRNA-Based COVID-19 Vaccine Gets CDSCO Approval

The CDSCO's Vaccine Subject Expert Committee stated that India's first mRNA-based COVID-19 vaccine is safe, acceptable, and immunogenic among trial participants. "It is a matter of great pride that Nation’s first mRNA-based vaccine is found to be safe... positions India on the Global Map for Novel Vaccine Development,” said Dr. Renu Swarup, Chairperson, BIRAC. The mRNA is a newly developed vaccine for protection against infectious diseases.